Abstract 2595: A novel dual-strand whole-genome sequencing (WGS) method for ultra-sensitive molecular residual disease detection (MRD)Andrew F. Slatter, Cande Rogert, Trevor Y. H. Ho et al.|Cancer Research|2026Cited by 0
Abstract 5300: Clinical utility of whole genome sequencing for upfront risk stratification in AML and MDS patientsKerry Fitzgerald, Taylor J. Jensen, Dennis D. Krutkin et al.|Cancer Research|2026Cited by 0